Moderna CEO Stephane Bancel has warned that the novel coronavirus might never disappear and there are high chances of it becoming an endemic disease

Full authorisation-better known as \"full pre-qualification\"-is a pre-requisite to sell the vaccine in the open market or for mass immunisation of healthy individuals who are not frontline workers

World Health Organization (WHO) chief scientist, Dr. Soumya Swaminathan's comments come in the backdrop of several Indian vaccine makers and medical experts complaining about the confusing manner in which DCGI has granted emergency use approvals for COVID-19 vaccines in India

The Indian Air Force will also use its exclusive military airfields and advanced landing grounds to transport the vaccine to the remotest parts of the country, including places like Arunachal Pradesh and Ladakh, the officials added

Premchand Godha's strategy for IPCA has not changed, it's about being integrated and focusSING on profitability

India's drug regulator in July had granted market approval for the Pneumococcal Polysaccharide Conjugate vaccine, after reviewing the phase 1, 2 and 3 clinical trial data submitted by the Pune-based firm

In India, RDIF has tied up with Dr Reddy's Laboratories for trials and regulatory approvals. Dr Reddy's recently began phase-2 and 3 clinical trials after getting requisite clearance

Rohit Shah, Co-founder & CEO, Hemp Horizons, says UN vote could lead to policy changes in terms of isolation and treatment of cannabis plant; he's elated over the fact that the historic vote in the United Nations will break the stigma around cannabis

The senior leader and former BJP President also said that remarks made by international entities on this issue were unjustifiable and uncalled for as India never interfered in internal matters of other countries

The applications are being examined on scientific basis, using the frameworks that are scientific, frameworks that are globally aligned and ensuring that the vaccine is safe, NITI Aayog member (health) Dr V K Paul said

Hours before the FDA authorised the first Covid-19 vaccine late Friday, White House told FDA chief he could face firing if vaccine was not cleared by day's end

As the country plans to vaccinate 30 crore people by July in the first phase, it may be difficult to bank alone on the Indian vaccines, especially Serum Institute's (SII) Covishield

Though Pfizer India says it remains committed to advance dialogue with Indian government to make the vaccine available for use, experts believe it will be difficult for its parent to supply adequate quantities of the vaccine

UN Secretary-General Antonio Guterres  has said that he intends to take the COVID-19 vaccine when it becomes available and he will do so publicly, asserting that vaccination for him is a moral obligation

India Stock Market Highlights Today: UltraTech Cement followed by Tata Steel, ONGC, IndusInd Bank, HDFC Bank, M&M, Infosys and Reliance Industries were among the top losers in the Sensex pack. On the other hand, Maruti, Nestle India, Titan and PowerGrid were among the gainers

Centre has announced two schemes to reduce import dependence in medicine manufacturing. Will they work this time?

Albert Bourla, the CEO of Pfizer, said the company will have tiered pricing for the middle-income countries (including, India) and will give the vaccine free in Africa

AIDAN wanted to know the exact processes and parameters for restricted emergency use approval of COVID-19 vaccine candidates in India, and whether and under what conditions interim results can be sufficient for seeking such an approval

India Stock Market Highlights Today: Maruti Suzuki, Hindalco, Tata Steel and GAIL India were the top gainers on Nifty rising up to 3.62%. SBI Life Insurance, Infosys, Bharti Airtel and Axis Bank were the top losers falling up to 1.79% on Nifty

Ministry of Health and Family Welfare is in discussion with three suppliers to place orders for syringes or is seeking to prepone deliveries of already placed orders with them